Larimar Therapeutics, Inc 10-K for FY2019

Headline figures

Fiscal year ended December 31, 2019, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue

$0

compared with $0 a year earlier

Net loss

$45.41M

compared with a net loss of $61.37M a year earlier